Skip to search formSkip to main contentSkip to account menu

eritoran

Known as: 3-O-decyl-2-deoxy-6-O-(2-deoxy-3-O-(3-methoxydecyl)-6-O-methyl-2-((1-oxo-11-octadecenyl)amino)-4-O-phosphonoglucopyranosyl)-2-((1,3-dioxotetradecyl)amino)-1-(dihydroxy phosphate)glucopyranose 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

DisaccharidesSugar Phosphates
E5564

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Using multiple 'omics strategies for novel therapies in sepsis
2018
2018
Behavioral effects of toll-like receptor-4 antagonist ‘eritoran’ in an experimental model of depression: role of prefrontal and hippocampal neurogenesis and &ggr;-aminobutyric acid/glutamate balance
Depression is the disease of the modern era. The lack of response to the available antidepressants, which were developed on the… 
Review
2014
Review
2014
Targeting myeloid differentiation 2 for treatment of sepsis.
Sepsis continues to be a leading cause of intensive care unit (ICU) death. Gram-negative bacteria are among the most important… 
Review
2014
Review
2014
What's new in the quagmire of sepsis?
2013
2013
Cbl-b Is a Critical Regulator of Macrophage Activation Associated With Obesity-Induced Insulin Resistance in Mice
We previously reported the potential involvement of casitas B-cell lymphoma-b (Cbl-b) in aging-related murine insulin resistance… 
Review
2013
Review
2013
Three-dimensional mapping of differential amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic activation by lipid A, antagonism by Eritoran and species…
A literature review concerning the unexpected species differences of the vertebrate innate immune response to lipid IVA was… 
2013
2013
Eritoran attenuates tissue damage and inflammation in hemorrhagic shock/trauma.
2012
2012
Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins
Lipid A, the active moiety of LPS, exerts its effects through interaction with TLR4, triggering a signalling cascade that results… 
2007
2007
Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility
Objective— Aim was to assess whether lipopolysaccharide (LPS)-induced decrease of total peripheral resistance depends on Toll… 
Highly Cited
2006
Highly Cited
2006
E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes
Abstract.Objective and designIn this ex vivo laboratory study, we investigated the effects of E5564 (eritoran), a toll-like… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)